Chemotherapy, as one of the primary ways to treat breast cancer, can put patients at high risk of side effects that can affect their adherence to treatment and quality of life. Alternative adjuvant therapy that can alleviate this effect can be beneficial for patients. A new study published in the journal Pharmacia showed that multi-strain probiotics can have impact on chemotherapy-related side effects through improved Karnofsky performance score and Blood Urea Nitrogen in breast cancer patients with chemotherapy.

In the United States, breast, colorectal, endometrial, pancreatic, and kidney cancers are becoming increasingly common among people under age 50, according to a study published in Cancer Discovery, a journal of the American Association for Cancer Research (AACR).

Women diagnosed with breast cancer who carry particular BRCA1 and BRCA2 genetic variants are offered surgery to remove the ovaries and fallopian tubes as this dramatically reduces their risk of ovarian cancer.  Now, Cambridge researchers have shown that this procedure – known as bilateral salpingo-oophorectomy (BSO) – is associated with a substantial reduction in the risk of early death among these women, without any serious side-effects.